Asthma, atopy and exhaled nitric oxide in a cohort of 6-yr-old New Zealand children

Pediatric Allergy and Immunology

Volumn 23, Issue 1, 2012, Pages 59-64

  Crane, Julian ^a   Lampshire, Philippa ^a   Wickens, Kristin ^a   Epton, Michael ^b   Siebers, Robert ^a   Ingham, Tristram ^a   Pattemore, Philip ^b   Town, Ian ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

Asthma; Atopy; Children; Exhaled nitric oxide; Specific IgE

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; NITRIC OXIDE;

ALLERGIC ASTHMA; ARTICLE; ATOPY; CHEMOLUMINESCENCE; CHILD; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SENSITIZATION; SKIN TEST; WHEEZING;

ALLERGENS; ANIMALS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; COHORT STUDIES; DERMATOPHAGOIDES PTERONYSSINUS; EXHALATION; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFLAMMATION; MALE; NEW ZEALAND; NITRIC OXIDE; QUESTIONNAIRES; RESPIRATORY SOUNDS; RESPIRATORY SYSTEM; SKIN TESTS;

EID: 84856393672     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2011.01227.x     Document Type: Article

References (30)

1. Louis R, Lau LCK, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000: 161: 9-16.
2. Burney P, Chinn S, Jarvis C, Luczynska C, Lai E. Variations in the prevalence of respiratory symptoms, self reported asthma attacks and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996: 9: 687-95.
3. Asher M, Anderson H, Stewart A, Crane J. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998: 12: 315-35.
4. Mitchell EA, Anderson HR, Freeling P, White PT. Why are hospital admission and mortality rates for childhood asthma higher in New Zealand than in the United Kingdom? Thorax 1990: 45: 176-82.
5. Jackson R, Sears MR, Beaglehole R, Rea HH. International trends in asthma mortality: 1970 to 1985. Chest 1988: 94: 914-8.
6. Warke TJ, Fitch PS, Brown V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002: 57: 383-7.
7. Silvestri M, Sabatini F, Sale R, et al. Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals. Pediatr Pulmonol 2003: 35: 358-63.
8. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. Increased nitric oxide production in the respiratory tract in asymptomatic pacific islanders: an association with skin prick reactivity to house dust mite. J Allergy Clin Immunol 2000: 105: 895-9.
9. Barreto M, Villa MP, Monti F, et al. Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms. Pediatr Allergy Immunol 2005: 16: 52-8.
10. Stein R, Martinez F. Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr Respir Rev 2004: 5: 155-61.
11. Epton M, Town G, Ingham T, et al. The New Zealand infant cohort study: assembly, demographics and investigations. BMC Public Health 2007: 7: 26.
12. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999: 160: 2104-17.
13. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995: 332: 133-8.
14. Barreto M, Villa MP, Martella S, et al. Exhaled nitric oxide in asthmatic and non asthmatic children: influence of type of allergen sensitization and exposure to tobacco smoke. Pediatr Allergy Immunol 2001: 12: 247-56.
15. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol 2005: 116: 744-9.
16. Franklin PJ, Turner SW, Le Souèef PN, Stick SM. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 2003: 58: 1048-52.
17. Nogalo B, Miric M, Maloca I, Turkalj M, Plavec D. Normal variation of bronchial reactivity in nonasthmatics is associated with the level of mite-specific IgE. J Asthma 2008: 45: 273-7.
18. Sawyer J, Kemp T, Shaw R, et al. Biological pollution in infant bedding in New Zealand: high allergen exposure during a vulnerable period. J Allergy Clin Immunol 1998: 102: 765-70.
19. Wickens K, Siebers R, Ellis I, et al. Determinants of house dust mite allergen in homes in Wellington New Zealand. Clin Exp Allergy 1997: 27: 1077-85.
20. Olin AC, Alving K, Toren K. Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy 2004: 34: 221-6.
21. Malmberg LP, Petèays T, Haahtela T, et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006: 41: 635-42.
22. Grammer L, Levitz D, Roberts M, Pruzansky JJ, Zeiss CR. Seasonal variation of IgE antibody specific for ragweed antigen E (IgE-a-AgE) from the basophil surface in patients with ragweed pollenosis. Int Arch Allergy Appl Immunol 1981: 66: 179-88.
23. Nahm DH, Park HS, Kang SS, Hong CS. Seasonal variation of skin reactivity and specific IgE antibody to house dust mite. Ann Allergy Asthma Immunol 1997: 78: 589-93.
24. Piacentini GL, Martinati L, Fornari A, et al. Antigen avoidance in a mountain environment: influence on basophil releasability in children with allergic asthma. J Allergy Clin Immunol 1993: 92: 644-50.
25. Stelmach I, Bobrowska-Korzeniowska M, Majak P, Stelmach W, Kuna P. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. Pulm Pharmacol Therap 2005: 18: 374-80.
26. Kovac K, Dodig S, Tjesic-Drinkovic D, Raos M. Correlation between asthma severity and serum IgE in asthmatic children sensitized to Dermatophagoides pteronyssinus. Arch Med Res 2007: 38: 99-105.
27. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005: 352: 2163-73.
28. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008: 372: 1065-72.
29. Buchvald F, Eiberg H, Bisgaard H. Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin Exp Allergy 2003: 33: 1735-40.
30. Wilson NM, James A, Uasuf C, et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001: 12: 125-32.